Genistein

Genistein

SCHEMBL5801778

O=c1c(-c2ccc(O)cc2)coc2cc(O)cc(O)c12.O=c1c(-c2ccc(O)cc2)coc2cc(O)ccc12

nearest known ligand 0.84

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 9/20 0.84
MAPT P10636 9/20 0.84
ALDH1A1 P00352 8/20 0.84
HPGD P15428 8/20 0.84
NPC1 O15118 8/20 0.84
RAB9A P51151 8/20 0.84
TP53 P04637 7/20 0.84
MEN1 O00255 6/20 0.84
KMT2A Q03164 6/20 0.84
CYP3A4 P08684 5/20 0.84
POLB P06746 5/20 0.84
CYP2C9 P11712 4/20 0.84
MAOA P21397 4/20 0.84
MAOB P27338 4/20 0.84
CYP2C19 P33261 4/20 0.84
ALOX15 P16050 4/20 0.84
AKR1B10 O60218 3/20 0.84
LMNA P02545 3/20 0.84
CYP19A1 P11511 3/20 0.84
HDAC6 Q9UBN7 3/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Genistein SCHEMBL554056 0.92 MAPT (1.00) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Genistein SCHEMBL19166 0.92 MAPT (1.00) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Genistein SCHEMBL29352944 0.92 MAPT (1.00) SMN1; SMN2MAPTALDH1A1HPGDNPC1
SCHEMBL14338667 0.91 XDH (0.70) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Formononetin SCHEMBL4223418 0.91 MAPT (0.83) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Formononetin SCHEMBL6312014 0.91 MAPT (0.83) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Genistein SCHEMBL551801 0.90 MAPT (0.97) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Genistein SCHEMBL551402 0.90 MAPT (0.97) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Genistein SCHEMBL38650814 0.90 MAPT (0.97) SMN1; SMN2MAPTALDH1A1HPGDNPC1
Genistein SCHEMBL551449 0.90 MAPT (0.97) SMN1; SMN2MAPTALDH1A1HPGDNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111655292-A Cellular biologicals and therapeutic uses thereof 旗舰先锋创新V股份有限公司 2020-09-11 CN disclosed
WO-2006091187-A1 ISOFLAVONOIDS FOR PREVENTING RADIATION- AND CHEMOTHERAPY- INDUCED WEIGHT LOSS LANDAUER MICHAEL R (US) 2006-08-31 WO disclosed
WO-2006067824-A1 PASTA WITH IMPROVED DIGERIBILITY COMPRISING ISOFLAVONES ALIVERIS S.P.A. (IT) 2006-06-29 WO disclosed
US-7056952-B1 for example, 3'-hydroxy-dihydrodaidzein, 5-hydroxy-O-demethylangolesin; for treating hormone dependent conditions and other diseases and disorders; anticarcinogenic agents G.J. CONSULTANTS PTY. LTD. (AU) 2006-06-06 US disclosed
US-20050031766-A1 Miso with good flavor containing high amount of isoflavone compounds MARUKOME CO., LTD. (JP) 2005-02-10 US disclosed
US-6849281-B2 Food product suitable for reducing low density lipoprotein cholesterol levels UNILEVER BESTFOODS, NORTH AMERICA, A DIVISION OF CONOPCO, INC. (US) 2005-02-01 US disclosed
CN-1120163-C Soybean isoflavone and its prepn process with macroporous adsorption resin CHINA FOOD FERMENTATION INDUST (CN) 2003-09-03 CN disclosed
EP-1159963-A1 Composition for and method of preventing or treating breast cancer Protein Technologies International, Inc. (US) 2001-12-05 EP disclosed
US-20010047033-A1 Composition for and method of preventing or treating breast cancer PROTEIN TECHNOLOGIES INTERNATIONAL, INC. 2001-11-29 US disclosed
US-6300367-B1 Composition for and method of preventing or treating breast cancer PROTEIN TECHNOLOGIES INTERNATIONAL, INC. 2001-10-09 US disclosed
WO-2001072126-A1 PEA AND LENTIL PRODUCTION-ENHANCING COMPOSITIONS AND METHOD USING SAME BIOS AGRICULTURE INC. (CA) 2001-10-04 WO disclosed